SETDB1 as a cancer target: challenges and perspectives in drug design (2024)
- Authors:
- USP affiliated authors: EMERY, FLAVIO DA SILVA - FCFRP ; LOTUFO, LETICIA VERAS COSTA - ICB ; TROSSINI, GUSTAVO HENRIQUE GOULART - FCF ; HASSANIE, HAIFA - FCF ; PENTEADO, ANDRÉ BERNDT - FCF ; ALMEIDA, LARISSA COSTA DE - ICB ; CALIL, RAISA LUDMILA - FCF
- Unidades: FCFRP; ICB; FCF
- DOI: 10.1039/D3MD00366C
- Subjects: NEOPLASIAS; MEDICAMENTO
- Language: Inglês
- Imprenta:
- Source:
- Título: RSC Medicinal Chemistry
- ISSN: 2632-8682
- Volume/Número/Paginação/Ano: v. 15, n. 5, p. 1424-1451, 2024
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
HASSANIE, Haifa et al. SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, v. 15, n. 5, p. 1424-1451, 2024Tradução . . Disponível em: https://dx.doi.org/10.1039/D3MD00366C. Acesso em: 02 out. 2024. -
APA
Hassanie, H., Penteado, A. B., Almeida, L. C. de, Calil, R. L., Emery, F. da S., Costa-Lotufo, L. V., & Trossini, G. H. G. (2024). SETDB1 as a cancer target: challenges and perspectives in drug design. RSC Medicinal Chemistry, 15( 5), 1424-1451. doi:10.1039/D3MD00366C -
NLM
Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Costa-Lotufo LV, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2024 out. 02 ] Available from: https://dx.doi.org/10.1039/D3MD00366C -
Vancouver
Hassanie H, Penteado AB, Almeida LC de, Calil RL, Emery F da S, Costa-Lotufo LV, Trossini GHG. SETDB1 as a cancer target: challenges and perspectives in drug design [Internet]. RSC Medicinal Chemistry. 2024 ; 15( 5): 1424-1451.[citado 2024 out. 02 ] Available from: https://dx.doi.org/10.1039/D3MD00366C - Human sirtuin 2 inhibitors, their mechanisms and binding modes
- Molecular modeling and structural comparison of leishmania sirtuin 2 enzymes, an epigenetic target in drug discovery
- Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity
- Novel [6]-gingerol triazole derivatives and their antiproliferative potential against tumor cells
- Virtual screening applied in hit identification as LSD1 inhibitors, a epigenetic target for cancer treatment
- Isolation, Absolute Configuration and Cytotoxic Activities of Alkaloids from Hippeastrum goianum (Ravenna) Meerow (Amaryllidaceae)
- Nanofibers of Jussara Pulp: a tool to prevent the loss of thermal stability and the antioxidant activity of anthocyanins after simulated digestion
- QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives
- Construction and validation of the 3D-structure of T. Cruzi sirtuin-2 by modeling threading
- Synthesis of two 'heteroaromatic rings of the future' for applications in medicinal chemistry
Informações sobre o DOI: 10.1039/D3MD00366C (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
